Aevis Victoria S.A. (AEVS.SW) SIX
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
Aevis Victoria S.A.
Address
Rue Georges-Jordil 4
Fribourg, 1700
Switzerland
Phone
41 26 350 02 02
Website
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
4731
First IPO Date
July 12, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Andri Färber | Chief Executive Officer of AD Swiss Net AG | 0 | 1962 |
| Anna Grabner | Chief Executive Officer of Genolier Innovation Hub | 0 | 1993 |
| Andreas Schollin-Borg | Chief Executive Officer of Batgroup | 0 | N/A |
| Dino Cauzza | Chief Executive Officer of Swiss Medical Network | 0 | 1972 |
| Eric Frey | Chief Executive Officer of Infracore | 0 | 1964 |
| Fabrice Zumbrunnen | Chief Executive Officer | 0 | 1969 |
| Mario Bernasconi | Chief Executive Officer of Well Gesundheit AG | 0 | 1975 |
| Antoine Hubert | Executive Chairman | 1.25M | 1966 |
| Michel Keusch | Chief Financial Officer & Chief Investment Officer | 0 | 1970 |
| Séverine Van der Schueren | Chief Administrative Officer | 0 | 1970 |
Description
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Real Estate. The group manages an extensive portfolio, which includes 22 hospitals providing 1,496 beds, and oversees 941 rooms within its real estate holdings, representing a total rentable area of 188,109 square meters. Beyond its core hospital services, Aevis Victoria offers telemedicine, ambulance transport, and day clinic facilities. Its broad range of business ventures further encompasses patient hotels, "better aging" programs, radiology institutes, pharmacies, ophthalmology clinics, property management, stem cell applications, cosmetic services, and publishing, alongside organizing various seminars. The company's corporate headquarters are situated in Fribourg, Switzerland, and it operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.